Jennifer Birstler

11PUBLICATIONS
60CO-AUTHORS
Radiation therapyPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 01, 2026
Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases.

|Apr 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors.

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Dec 07, 2023
Assessing the Impact of a Serious Game (MedSMARxT: Adventures in PharmaCity) in Improving Opioid Safety Awareness Among Adolescents and Parents: Quantitative Study.

Olufunmilola Abraham, Tyler James McCarthy, Jen Zaborek

|May 31, 2023
A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials.

Jens Eickhoff, Jen Zaborek, Guanhua Chen

|Apr 04, 2023
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.

Alexander A Pieper, Dan V Spiegelman, Mildred A R Felder

Pageof 2

Frequent Collaborators

3 joint publications

KyungMann Kim

3 joint publications

Zachary S Morris

3 joint publications

Paul M Sondel

3 joint publications

Guanhua Chen